Infliximab and the bone in Crohn's disease

Aliment Pharmacol Ther. 2005 Apr 1;21(7):918-9. doi: 10.1111/j.1365-2036.2005.02434.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Bone Density / drug effects*
  • Collagen / metabolism
  • Collagen Type I
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infliximab
  • Osteogenesis / drug effects*
  • Peptides / metabolism

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Collagen Type I
  • Gastrointestinal Agents
  • Peptides
  • collagen type I trimeric cross-linked peptide
  • Collagen
  • Infliximab